http://rdf.ncbi.nlm.nih.gov/pubchem/patent/US-2014287442-A1
Outgoing Links
| Predicate | Object |
|---|---|
| assignee | http://rdf.ncbi.nlm.nih.gov/pubchem/patentassignee/MD5_aecb5d203a63cdb920c41dbf7a44925e |
| classificationCPCAdditional | http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/G06F19-702 http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/G16C20-10 |
| classificationCPCInventive | http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/G01N24-088 http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/G01N30-00 http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/G16C20-10 http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/G01N33-15 http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/G01N33-68 http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/G01N33-6854 |
| classificationIPCInventive | http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/G01N30-00 http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/G01N33-68 http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/G01N24-08 |
| filingDate | 2014-03-18-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
| inventor | http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_480957558d18a1bac9cb33d2acf9e1a6 |
| publicationDate | 2014-09-25-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
| publicationNumber | US-2014287442-A1 |
| titleOfInvention | Method for determining degree of modified potency of bipathic medicament |
| abstract | The invention comprises a method for determining degree of modified potency of a bipathic medicament. A bipathic medicine is a medicament comprising a therapeutic component and a homeopathic component, wherein the homeopathic component has some physical, chemical or biological affect on the therapeutic component and/or the pharmacological efficacy thereof. An analytical measurement of at least one characteristic parameter of the therapeutic form is made prior to its interaction with the activated-potentiated form. The same analytical measurement(s) are made and after interaction between the therapeutic and activated-potentiated forms. This data is used to confirm the presence of any modified potency is caused by the presence of molecular form in the activated-potentiated form. Further, the claimed analytical measurement of at least one characteristic parameter of the therapeutic form prior to its interaction with the activated-potentiated form and again after such interaction serves to quantify the degree of modifying potency associated with the activated-potentiated form in relative dimensionless activity units (release activity). |
| isCitedBy | http://rdf.ncbi.nlm.nih.gov/pubchem/patent/US-2014287448-A1 http://rdf.ncbi.nlm.nih.gov/pubchem/patent/WO-2017147616-A1 http://rdf.ncbi.nlm.nih.gov/pubchem/patent/US-9945798-B2 http://rdf.ncbi.nlm.nih.gov/pubchem/patent/US-9945868-B2 |
| priorityDate | 2013-03-18-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
| type | http://data.epo.org/linked-data/def/patent/Publication |
Incoming Links
Total number of triples: 62.